Wednesday, June 10, 2026
🇺🇸 FDA

P1 · Therapeutic area intelligence

Oncology patent intelligence

Anticancer agents, immuno-oncology, ADC, and oncology patent filings — grants, expirations, and assignee activity.

Patents
2,004

Quick answer

2,004 US pharmaceutical patents in our index match Oncology title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.

  1. US 6818213

    Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Tue Nov 16 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  2. US 6818749

    Variants of humanized anti carcinoma monoclonal antibody cc49

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 16 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  3. US 6815574

    Methods of simulating human prostate cancer progression

    The Regents of the University of California · Granted Tue Nov 09 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  4. US 6806363

    Cobalamin conjugates useful as antitumor agents

    Minnesota, Regents of the University · Granted Tue Oct 19 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  5. US 6806354

    Methods and compositions for inducing autoimmunity in the treatment of cancers

    The Board of Regents of the University of Texas System · Granted Tue Oct 19 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  6. US 6803386

    Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancer

    United Therapeutics Corporation · Granted Tue Oct 12 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  7. US 6797721

    Phorboxazole derivatives for treating cancer

    Regents of the University of Minnesota · Granted Tue Sep 28 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  8. US 6794188

    Retrovirus vectors derived from avian sarcoma leukosis viruses permitting transfer of genes into mammalian cells and therapeutic uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 21 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  9. US 6783760

    Combined cancer treatment methods using therapeutic conjugates that bind to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Tue Aug 31 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  10. US 6780586

    Methods of diagnosing breast cancer

    Protein Design Labs, Inc. · Granted Tue Aug 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  11. US 6780995

    Activated iododerivatives for the treatment of cancer and aids

    Isotechnika, Inc. · Granted Tue Aug 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  12. US 6780984

    Method for prognosing cancer and the proteins involved

    Northwestern University · Granted Tue Aug 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  13. US 6762020

    Methods of diagnosing breast cancer

    Protein Design Labs, Inc. · Granted Tue Jul 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  14. US 6756036

    Methods for treating cancer using PSCA antibodies and fragments thereof

    The Regents of the University of California · Granted Tue Jun 29 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  15. US 6756399

    Use of lipoxygenase inhibitors and PPAR ligands as anti-cancer therapeutic and intervention agents

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 29 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  16. US 6749853

    Combined methods and compositions for coagulation and tumor treatment

    The Board of Regents of the University of Texas System · Granted Tue Jun 15 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  17. US 6737251

    Nucleotide and deduced amino acid sequences of tumor gene Int6

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 18 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  18. US 6723338

    Compositions and methods for treating lymphoma

    The Board of Regents of the University of Texas System · Granted Tue Apr 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  19. US 6717017

    Total synthesis of antitumor acylfulvenes

    The Regents of the University of California · Granted Tue Apr 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  20. US 6703050

    Methods and compositions for the prevention or treatment of cancer

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Mar 09 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  21. US 6699842

    Dominant negative deletion mutants of C-jun and their use in the prevention and treatment of cancer

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 02 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  22. US 6689362

    Method for treating T-lineage leukemias and lymphomas using a CD7-specific monoclonal antibody (TXU-7) linked to the pokeweed antiviral protein (PAP)

    Regents of the University of Minnesota · Granted Tue Feb 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  23. US 6689561

    Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression and cancer treatment

    The Regents of the University of California · Granted Tue Feb 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  24. US 6682890

    Methods of diagnosing and determining prognosis of colorectal cancer

    Protein Design Labs, Inc. · Granted Tue Jan 27 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  25. US 6680172

    Treatments and markers for cancers of the central nervous system

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  26. US 6680196

    Gene that is amplified and overexpressed in cancer and methods of use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Jan 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  27. US 6680171

    I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  28. US 6677309

    Anti-cancer drug aldehyde conjugate drugs with enhanced cytotoxicity compounds, compositions and methods

    The Regents of the University of Technology Office of Technology Transfer · Granted Tue Jan 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  29. US 6676973

    Method of treating ovarian cancers with cadmium

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  30. US 6673559

    Met proto-oncogene and a method for predicting breast cancer progression

    The United States of America as Represented by the Government of the Department of Health and Human Services · Granted Tue Jan 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  31. US 6664263

    1,8-naphthalimide imidazo{4,5,1-de}acridones with anti-tumor activity

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 16 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  32. US 6649411

    Methods of inhibiting cancer cells with ADNF III antisense oligonucleotides

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 18 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  33. US 6645465

    Annexin proteins and autoantibodies as serum markers for cancer

    MICHIGAN, REGENTS OF THE UNIVERSITY OF, THE · Granted Tue Nov 11 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  34. US 6639105

    Illudin analogs useful as antitumor agents

    The Regents of the University of California · Granted Tue Oct 28 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  35. US 6630464

    Cyclin dependent kinase (CDK)4 inhibitors and their use for treating cancer

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  36. US 6623938

    I-flice, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 23 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  37. US 6610302

    Anti-tumor activity of Ea-2 and Ea-4-peptide of pro-IGF-I

    UNIVERSITY OF CONNECTICUT · Granted Tue Aug 26 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  38. US 6593456

    Tumor necrosis factor receptor releasing enzyme

    The Regents of the University of California · Granted Tue Jul 15 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  39. US 6582725

    Human PEA3 is a tumor suppressor for cancer cells

    The Board of Regents of the University of Texas System · Granted Tue Jun 24 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  40. US 6579857

    Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors

    EVANSTON NORTHWESTERN HEALTHCARE RESEARCH INSTITUTE · Granted Tue Jun 17 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  41. US 6579684

    Assay of YKL-40 as a marker for cancer

    The Regents of the University of California · Granted Tue Jun 17 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  42. US 6579893

    Use of troglitazone and related compounds for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Tue Jun 17 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  43. US 6565827

    Radioimmunotherapy of lymphoma using anti-CD20 antibodies

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 20 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  44. US 6562347

    Chemokine-tumor antigen fusion proteins as cancer vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 13 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  45. US 6558668

    Methods for detection and treatment of neural cancers

    The Regents of the University of California · Granted Tue May 06 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  46. US 6552181

    Basal cell carcinoma tumor supressor gene

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  47. US 6551585

    Use of tumor necrosis factor as an adjuvant

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  48. US 6551588

    Tumor radiosensitization using gene therapy

    The Regents of the University of California · Granted Tue Apr 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many Oncology patents are indexed?

2,004 patents match our Oncology classifier (title keywords in USPTO records).

Is this legal or medical advice?

No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.